Earnings summaries and quarterly performance for BIO KEY INTERNATIONAL.
Executive leadership at BIO KEY INTERNATIONAL.
Board of directors at BIO KEY INTERNATIONAL.
Research analysts who have asked questions during BIO KEY INTERNATIONAL earnings calls.
Jack Vander Aarde
Maxim Group
6 questions for BKYI
Also covers: ALRM, AMPG, BNAI +10 more
DC
Dan Camas
Private Investor
2 questions for BKYI
DC
Dan Cummings
Private Investor
1 question for BKYI
DK
Dan Khamis
private investor
1 question for BKYI
DT
Dan Thomas
private investor
1 question for BKYI
UA
Unknown Attendee
Private Investor
1 question for BKYI
Also covers: PPSI, REKR
Recent press releases and 8-K filings for BKYI.
BIO-key International and Visualforma Partner for Digital Identity Solutions in Portugal
BKYI
New Projects/Investments
- BIO-key International has formed a strategic partnership with Visualforma, a Portuguese technology integrator, to launch a new business line focused on Portuguese municipal councils.
- This partnership will lead the nationwide rollout of BIO-key’s Identity and Access Management (IAM) and biometric authentication technologies across Portugal’s public-sector ecosystem, which comprises more than 250 government organizations.
- The deployment framework has already been executed, with BIO-key’s full IAM and biometric security portfolio already operational in a major tourist city to secure access to critical digital services.
- The program aims to strengthen cybersecurity, enhance compliance, and improve access to public digital services for employees, residents, and visitors, supporting the digital transformation of public services in Portugal.
3 days ago
BIO-key International Reports Q3 2025 Results and Business Outlook
BKYI
Earnings
Product Launch
Guidance Update
- BIO-key International reported Q3 2025 revenue of $1.5 million and a net loss of $965,000, or $0.15 per share. This revenue was roughly in line with the first two quarters of 2025, but a decrease from $2.1 million in Q3 2024, primarily attributed to the timing of larger customer orders.
- The company maintained a strong gross margin of 77% in Q3 2025 and successfully reduced operating expenses by 8% to $2.1 million compared to Q3 2024. Operating expenses were also reduced by over 10% through the first nine months of 2025.
- As of September 30, 2025, BIO-key had $2 million in cash. Subsequent to the quarter's close, the company raised approximately $3 million net of fees from a warrant exercise transaction, significantly enhancing its cash liquidity.
- Management expects a strong close to 2025 and anticipates a large banking customer to renew their contract for $1-$3 million in early 2026. The company's Annual Recurring Revenue (ARR) is estimated to be in the $6-$7 million range, supported by renewal rates exceeding 90%.
- In Q3 2025, BIO-key introduced its new FBI FAP 20 certified EcoID 3 fingerprint scanner and is preparing a significant update to its PortalGuard identity platform (Version 7), with general availability expected in late Q1 or early Q2 2026.
Nov 14, 2025, 3:00 PM
BIO-key International Reports Q3 2025 Results with Strong Margins and Post-Quarter Funding
BKYI
Earnings
Guidance Update
New Projects/Investments
- BIO-key International reported Q3 2025 revenue of $1.5 million and a net loss of $965,000, or $0.15 per share. Year-to-date revenue was slightly under $5 million.
- The company maintained a strong gross margin of 77% in Q3 2025, while operating expenses decreased 8% to $2.1 million.
- Subsequent to the quarter, BIO-key significantly enhanced its liquidity by raising approximately $2.9 million in net proceeds from a warrant exercise. As of September 30, 2025, current assets stood at $3.7 million, including $2 million in cash.
- Looking ahead, the company expects a strong close to 2025 and anticipates a $1-$3 million contract renewal from a major banking customer in early 2026. They also launched the EcoID 3 fingerprint scanner and plan a major PortalGuard platform update in early 2026.
Nov 14, 2025, 3:00 PM
BIO-key International Reports Q3 2025 Results and Post-Quarter Funding
BKYI
Earnings
Product Launch
Guidance Update
- BIO-key International (BKYI) reported Q3 2025 revenue of approximately $1.55 million, marking a $595,000 decrease year-over-year compared to Q3 2024, primarily attributed to the timing of larger customer orders. The company recorded a Q3 2025 net loss of $965,000, or $0.15 per share, while maintaining a strong gross margin of 77%.
- Operating expenses were reduced by 8% to $2.1 million in Q3 2025 compared to Q3 2024, and by over 10% year-to-date through the first nine months of 2025, as the company focuses on lowering its break-even levels.
- Subsequent to the close of Q3 2025, BIO-key raised approximately $3 million net of fees through a warrant exercise transaction, significantly expanding its cash liquidity. As of September 30, 2025, current assets stood at $3.7 million, including $2 million in cash.
- The company anticipates a large banking customer to renew their subscription contract in early 2026 for an expected $1 million to $3 million. BIO-key also launched its FBI FAP 20 certified EcoID III fingerprint scanner and plans a significant update to its PortalGuard identity platform (Version 7) for general availability in late Q1 or early Q2 2026.
Nov 14, 2025, 3:00 PM
BIO-key International, Inc. Reports Q3 2025 Results
BKYI
Earnings
Guidance Update
New Projects/Investments
- BIO-key International, Inc. reported Q3 2025 total revenues of $1.55 million, a decrease from $2.14 million in Q3 2024, primarily due to large orders in the prior year period.
- The company's net loss for Q3 2025 was ($964,849), or ($0.15) per share, compared to a net loss of ($738,959), or ($0.39) per share, in Q3 2024.
- BIO-key expects full-year 2025 revenue to be in the range of $6.5 million to $7 million. As of September 30, 2025, cash and cash equivalents stood at $2.0 million, significantly up from $0.4 million at December 31, 2024, with an additional $3.1 million in gross proceeds raised from a warrant exercise on October 27, 2025.
- The company launched its next-generation EcoID III USB fingerprint scanner and secured a significant new deployment with a Middle East defense sector organization as part of its CyberDefense Initiative.
Nov 14, 2025, 1:45 PM
BIO-key International Reports Q3 2025 Results and Post-Quarter Financing
BKYI
Earnings
Guidance Update
Product Launch
- BIO-key International, Inc. reported Q3 2025 total revenues of $1.55 million, a decrease from $2.14 million in Q3 2024, and a net loss of ($964,849), or ($0.15) per share.
- Post-quarter, on October 27, 2025, the company raised $3.1 million in gross proceeds from a warrant exercise agreement, which was used to prepay approximately $450,000 of a new promissory note and satisfy another note for $327,991.
- BIO-key launched its EcoID III USB fingerprint scanner and secured a significant new deployment with a Middle East defense sector organization, contributing to a full-year 2025 revenue expectation of $6.5-$7 million.
Nov 14, 2025, 1:30 PM
BIO-key International Partners with VaporVM for Middle East and Africa Expansion
BKYI
New Projects/Investments
- BIO-key International (BKYI) has entered into a strategic partnership with VaporVM, a global leader in cloud, cybersecurity, and managed services.
- This collaboration is designed to expand the delivery of BIO-key's Identity and Access Management (IAM) and biometric authentication solutions to enterprises, public sector organizations, and institutions across the Middle East and Africa.
- VaporVM will integrate and promote BIO-key’s full range of IAM and biometric solutions, providing local expertise, technical support, partner enablement, and deployment services in the region.
- The partnership leverages VaporVM’s cloud-native expertise and regional presence with BIO-key’s PortalGuard® IAM platform to offer secure digital transformation solutions for organizations operating across AWS, Azure, and Google Cloud Platform (GCP).
Nov 12, 2025, 9:00 AM
BIO-key Secures Major Middle East Defense Sector Deployment
BKYI
New Projects/Investments
- BIO-key International (NASDAQ: BKYI) has secured a significant new deployment with a major defense-sector security organization in the Middle East.
- This deployment utilizes BIO-key’s advanced biometric and multi-factor authentication technologies to secure critical infrastructure and sensitive access environments.
- The contract represents one of BIO-key’s largest security-sector deployments in the region to date, expanding its footprint in high-assurance government and defense environments.
- This project is a result of BIO-key’s new strategic partnership with Cloud Distribution, a leading Saudi-based Value-Added Distributor.
Nov 7, 2025, 9:00 AM
BIO-key International Introduces EcoID III USB Fingerprint Scanner
BKYI
Product Launch
- BIO-key International, Inc. announced the launch of its next-generation EcoID III USB Fingerprint Scanner on October 21, 2025.
- The EcoID III features liveness detection, FBI FAP 20, PIV, and NIBSS certifications, and encrypted device-to-host communication.
- This new scanner is expected to significantly lower the price point for high-quality fingerprint scanners, and first volume orders are already being delivered to government customers.
Oct 21, 2025, 12:28 PM
BIO-KEY INTERNATIONAL INC enters into a secured promissory note agreement
BKYI
Debt Issuance
New Projects/Investments
- BIO-KEY INTERNATIONAL, INC. secured a $1,130,000.00 principal amount senior secured promissory note from Streeterville Capital, LLC on September 30, 2025.
- The company received $1,000,000.00 in net proceeds, after an original issue discount of $125,000.00 and $5,000.00 for transaction expenses were deducted from the principal.
- The note carries an interest rate of 9% per annum and has a maturity period of 18 months from the issuance date.
- Repayments are subject to a 7% exit fee, and the lender has the right to redeem up to $135,000 of principal per month starting six months after issuance.
- The obligation is secured by a lien on substantially all of the Company's assets and is guaranteed by its subsidiary, PistolStar, Inc..
Oct 3, 2025, 9:01 PM
Quarterly earnings call transcripts for BIO KEY INTERNATIONAL.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more